Home
Mailbox
Boards
Favorites
Whats Hot!
Login - Join Now!
Search
Search Type
Board
Post
Member
CytoDyn Inc CYDY
Board Mod:
HHIGambler
Asst Mods:
Evil Rabbit
CaptnAmerca
mightycydy
Last Post: 10/29/2025 1:23:52 PM
Board Marks: 394
Posts Today: 0
Board Views Today: 1829
CytoDyn Inc CYDY
CytoDyn Inc. (OTCQB: CYDY)
Company Website:
http://www.cytodyn.com/
CYDY Company Profile
CYDY Time & Sales
CYDY Recent News
CYDY Filings
CYDY Financials
CYDY Buy Rating
sean007
08/13/2025 3:44:49 PM
Quiet period,...is just that...take it
(1)
hoops
08/13/2025 1:29:39 PM
How much does Cytodyn benefit if the
(1)
My69z
08/13/2025 7:16:57 AM
How's that a damper -- not even close &
(4)
KenChowder
08/13/2025 6:03:10 AM
Good post, My. And obviously you are
(15)
My69z
08/12/2025 7:11:50 PM
Timelines: 5 months past @ March 18th:
(24)
brentie
08/12/2025 6:42:29 PM
From Reddit...
(16)
MidnightRider
08/12/2025 12:24:22 PM
Agreed jeff67....the pendulum perhaps
(12)
Crujones1985
08/12/2025 12:09:11 PM
I also think that a lot of things are
(15)
craigakess
08/12/2025 10:35:37 AM
Wait...what? You think we have anything
(3)
Plotinus
08/12/2025 7:55:45 AM
Liking once again your x-ray vision on
(10)
Respert24
08/12/2025 7:45:35 AM
I don't disagree, though in this case I
(14)
jeff67
08/12/2025 1:01:47 AM
The company is overdue for a
(20)
sean007
08/11/2025 7:12:54 PM
Prasad is back in...SO What... and how
(2)
Crujones1985
08/11/2025 7:05:29 PM
I can understand and agree with that
(4)
sean007
08/11/2025 6:59:56 PM
MORE...later this week.
(3)
Mr3Putt
08/11/2025 6:12:39 PM
It feels like the shareholder community
(11)
MidnightRider
08/11/2025 2:52:07 PM
Sounds like a great idea buddyboy
(3)
Crujones1985
08/11/2025 2:36:12 PM
At these prices its a great
(4)
Evil Rabbit
08/11/2025 2:07:43 PM
Emmitt still has me on IGNORE so I
(16)
craigakess
08/11/2025 12:52:18 PM
Emmitt still has me on IGNORE so I
(9)
mountaineer
08/11/2025 12:38:31 PM
I honestly did not think I would see SP
(4)
Emmitt
08/10/2025 8:09:34 PM
Craig has a problem with me. I blocked
(4)
Buddyboy20
08/10/2025 7:52:13 PM
I didn't even think of those guys. Do
(9)
sean007
08/10/2025 7:39:09 PM
Buddy,...what about communicating with
(3)
craigakess
08/10/2025 7:32:00 PM
Emmit says management allegedly won't
(4)
Emmitt
08/10/2025 6:19:48 PM
BB. While management at CYDY seems a
(5)
Buddyboy20
08/10/2025 5:13:24 PM
I sent Investor Relations an email,
(16)
sean007
08/10/2025 4:30:05 PM
The
(4)
Emmitt
08/10/2025 4:02:35 PM
Folks on the west coast know anyone
(5)
Ramjet
08/10/2025 1:49:00 PM
I think faith, hope, charity,
(30)
MGK_2
08/09/2025 8:54:23 PM
Only a trial or study gets us visible.
(8)
sean007
08/09/2025 8:29:12 PM
I sometimes get the eerie
(4)
Mr3Putt
08/09/2025 7:48:28 PM
Merck Gilead Novo GSK Roche let them
(6)
MGK_2
08/09/2025 7:30:57 PM
Boy, given the statements in the link,
(11)
sean007
08/09/2025 6:54:33 PM
Gilead's fibrotic disease pipeline is
(6)
sean007
08/09/2025 3:39:23 PM
"So much ado...about nothing"...there
(5)
cardamine
08/09/2025 2:51:48 PM
I was disagreeing with the phrase
(5)
Figgs
08/09/2025 12:45:48 PM
Good, so we are in agreement! I meant
(4)
Mr3Putt
08/09/2025 11:43:47 AM
Weve gone full Lord of the Flies.
(10)
Emmitt
08/09/2025 11:38:42 AM
Reading the dialogue on some of these
(6)
cardamine
08/09/2025 11:31:09 AM
Wow...is that your full capacity for
(7)
Figgs
08/09/2025 11:16:40 AM
So are we in the business of selling
cardamine
08/09/2025 10:46:47 AM
oy that sounds like a con...Mehmet Oz
(8)
Figgs
08/09/2025 8:25:07 AM
When I walk across Central Park to 5th
(6)
docj
08/09/2025 7:10:56 AM
Anyone happen to have a list of alias
(1)
weasel667
08/09/2025 4:09:53 AM
Connections (networking), top knowledge
(2)
My69z
08/09/2025 3:50:40 AM
Your right....it's CCR5/CD4+ occupancy
(3)
KenChowder
08/09/2025 2:50:16 AM
My writes: I have read in our patent
(22)
misiu143
08/09/2025 12:13:05 AM
Well , I dont know how long you are
(14)
My69z
08/08/2025 11:16:06 PM
I have read in our patent applications
(8)
Newer
Older
Recent Articles
Electrolux Group Reports Positive Growth in Q3 2025 Results
Flow Traders Reports 3Q 2025 Results with Insights
Key Advantages of Cross-Straits Development for Unity
Electrolux Group Reports Strong Q3 Performance in 2025
Aker Horizons ASA Unveils Key Financials for Q3 2025
Electrolux Group Reports Strong Q3 Performance and Future Plans
Hikvision Launches Innovative AI Solutions to Support SMBs Growth
Revolutionizing AI Podcasts: The Soul App's New Voice Model
General Motors' Workforce Reductions and EV Market Challenges
Nobu Hospitality Expands Global Presence with Luxury Residences
United Imaging Healthcare Sees Growth in Q3 2025 Revenue
ING Achieves Impressive Results with €1.787 Billion Profit
Clariant Reports Growth in Q3 2025 EBITDA Margin Amid Challenges
Arcadis Q3 2025 Growth and Margin Expansion Overview
dsm-firmenich Delivers Promising Q3 2025 Update Insights
Pluxee Celebrates Strong Financial Performance for Fiscal 2025
Hansa Biopharma's Major Milestones and Financial Insights
Hansa Biopharma's Q3 Success and Future Growth Plans
Hansa Biopharma Shows Positive Progress with Imlifidase Trials
ING's Successful Share Buyback and New €1.6 Billion Plan
argenx Achieves Significant Milestones in Q3 2025
ING's Major Buyback and New Shareholder Distribution Plan
Jim Cramer Advocates Sharing Nvidia's Advanced Chips with China
Exploring the Expanding Horizons of Sustainable Materials Growth
The Future of Main Landing Gears Market and Industry Insights
Idorsia Reports Impressive Growth in QUVIVIQ Sales and Financials
argenx Excels with Strong Third Quarter Performance and Plans
Scatec Updates on Third Quarter Performance and Future Plans
PixVerse Partners with UNU Network to Promote AI for Good
United Imaging Healthcare's Revenue Growth Spikes in Q3 2025
Roche's Strategic Acquisition of 89bio: Making Waves in Biopharma
Nobu Hospitality Launches Exquisite Residences and Dining in Kuwait
Pluxee Announces Impressive Fiscal 2025 Performance Highlights
Pulsar Helium's Jetstream #3 Well Reaches Major Milestone
Arcadis Reports Q3 2025 Growth With Expanding Margins
Ontex's Q3 Results Show Strong Progress Despite Market Challenges
dsm-firmenich Reports Encouraging Q3 2025 Performance Insights
Clariant Reports Growth in EBITDA Margin amidst Challenges
EfTEN Real Estate Fund's Positive Growth Trajectory Unveiled
Telenor's Nordic Security Report Highlights Urgent Cyber Threats
TGS ASA Announces Ex-Dividend Trading at NOK 1.56 Today
Crédit Agricole S.A. Reports Strong Q3 and 9M 2025 Earnings
ING Reports Impressive €1.787 Billion Net Income for 2025 Q3
AI Computing Power: A Sustainable Solution for Retirement
Innovative Sugar Reduction Solutions Unveiled by Samyang Corp
Societe Generale Shows Impressive Financial Growth in Q3 2025
FMC Corporation Faces Significant Stock Decline After Earnings Report
Piramal Pharma Solutions Forms New Alliance with IntoCell
Piramal Pharma and IntoCell Collaborate for Advanced Bioconjugates
AI Computing Power: A Solution for America’s Retirement Dilemma